The Residues AGDV of Recombinant γ Chains of Human Fibrinogen Must Be Carboxy-Terminal to Support Human Platelet Aggregation

Summary

The carboxy-terminus of the γ chain of fibrinogen contains a sequence which is believed to be one of the domains that interacts with glycoprotein (GP) IIb/IIIa to support platelet aggregation. A normal variant of fibrinogen exists in which the four carboxy-terminal amino acids are replaced by 20 amino acids. This variant, known as γ’, has been reported to bind less effectively to platelets. The purpose of the present study was to engineer novel proteins to determine what differences in amino acid sequence between the γ and γ’ chains influence the interaction of the carboxyterminus with GPIIb/IIIa. In this regard, the γ chain cDNA in a bacterial plasmid expression vector was modified by oligonucleotide-directed mutagenesis to produce recombinant γ chains with amino acid changes in the carboxy-terminus which reflect the differences between γ and γ’. The recombinant γ chain with an unmodified carboxy-terminus supported adenosine diphosphate (ADP)-induced platelet aggregation to the same extent as intact fibrinogen. In contrast, the ability of γ’ 427 (the recombinant γ’ variant) and γ 427 (where the 16 amino acid γ’ extension [412–427] was added to the carboxy-terminus of γ) to support platelet aggregation was markedly reduced. In addition, the extent of ADP-induced platelet aggregation was decreased in the presence of γ’ 411 (where amino acids 408–411 in γ were replaced with amino acids 408–411 in γ’), while γ 407 (where the four carboxy-terminal amino acids were deleted) was not capable of supporting aggregation. These findings demonstrate that the four residues AGDV are not only required but must be carboxy-terminal to support platelet aggregation.

• REFERENCES

• 1 Tomikawa M, Iwanmoto M, Soderman S, Blombäck B. Effect of fibrinogen on ADP-ïnduced platelet aggregation. Thromb Res 1980; 19: 841-855
• 2 Marguerie GA, Ardaillou N, Cherel G, Plow EF. The binding of fibrinogen to its platelet receptor. Involvement of the D domain. J Biol Chem 1982; 257: 11872-11875
• 3 Kloczewiak M, Timmons S, Hawiger J. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen γ chain. Biochem Biophys Res Commun 1982; 107: 181-187
• 4 Kloczewiak M, Timmons S, Lukas TJ, Hawiger J. Platelet receptor recognition site on human fibrinogen. Synthesis and structure function relationship of peptides corresponding to the carboxy-terminal segment of the γ chain. Biochemistry 1984; 23: 1767-1774
• 5 Kloczewiak M, Timmons S, Bednarek MA, Sakon M, Hawiger J. Platelet receptor recognition domain on the γ chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 1989; 28: 2915-2919
• 6 Stathakis NE, Mosesson MW, Galanakis DK, Menache D. Human fibrinogen heterogeneities. Preparation and characterization of γ and γ’ chains. Thromb Res 1978; 13: 467-475
• 7 Francis CW, Marder VJ, Martin SE. Demonstration of a large molecular weight variant of the γ chain of normal human plasma fibrinogen. J Biol Chem 1980; 255: 5599-5604
• 8 Wolfenstein-Todel C, Mosesson MW. Carboxy-terminal amino acid sequence of a human fibrinogen γ chain variant (γ’). Biochemistry 1981; 20: 6146-6149
• 9 Fornace Jr AJ, Cummings DE, Comeau CM, Kant JA, Crabtree GR. Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3’ end of the gene produces γA and γB forms of γ-fibrinogen. J Biol Chem 1984; 259: 12826-12830
• 10 Chung DW, Davie EW. γ and γ’ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236
• 11 Harfenist EJ, Packham MA, Mustard JF. Effects of variant γ chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets. Blood 1984; 64: 1163-1168
• 12 Peerschke EIB, Francis CW, Marder VJ. Fibrinogen binding to human blood platelets: effect of γ chain carboxyterminal structure and length. Blood 1986; 67: 385-390
• 13 Amrani DL, Newman PJ, Meh D, Mosesson MW. The role of fibrinogen Aα chains in ADP-induced platelet aggregation in the presence of fibrinogen molecules containing γ’ chains. Blood 1988; 72: 919-924
• 14 Bolyard MG, Lord ST. High-level expression of a functional human fibrinogen gamma chain in Escherichia coli. . Gene 1988; 66: 183-192
• 15 Caruthers MH. Gene synthesis machines. DNA chemistry and its uses. Science 1985; 230: 281-285
• 16 Nelson M, Christ C, Schildkraut I. Alteration of apparent restriction endonuclease recognition specificities by DNA methylases. Nucleic Acids Res 1984; 12: 5165-5173
• 17 Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene 1985; 33: 103-119
• 18 Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166: 557-580
• 19 Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY: 1982
• 20 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
• 21 Biggin MD, Gibson TJ, Hong GF. Buffer gradient gels and ³⁵S label as an aid to rapid DNA sequence determination. Proc Natl Acad Sci USA 1983; 80: 3963-3965
• 22 Hawiger J, Timmons S, Kloczewiak M, Strong DD, Doolittle RF. γ and α chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci USA 1979; 76: 2068-2071
• 23 Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriphage T4. Nature 1970; 227: 680-685
• 24 Towbin H, Stalhelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354
• 25 Matsueda GR, Ball EL, Bernatowicz MS. A monoclonal antibody specific for the C terminus of fibrinogen and fibrin gamma chains. FASEB J 1988; 2: A1411
• 26 Altieri DC, Agbango FR, Plescia J, Ginsberg MH, Edgington TS. Plow EF A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD 18). J Biol Chem 1990; 265: 12119-12122
• 27 Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma by centrifugation and washing. Meth Enzymol 1989; 169: 03-11
• 28 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 29 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338
• 30 Maeda K, Sczakiel G, Hofmann W, Menetret J, Wittinghofer A. Expression of Native Rabbit Light Meromyosin in Escherichia coli. Observation of a powerful internal translation initiation site. J Mol Biol 1989; 205: 269-273
• 31 Preibisch G, Ishiahara H, Tripier D, Leineweber M. Unexpected translation initiation within the coding region of eukarotic genes expressed in Escherichia coli. . Gene 1988; 72: 179-186
• 32 Board PG, Pirece K, Coggan M. Expression of functional coagulation factor XIII in Escherichia coli. . Thromb Haemostas 1990; 63: 235-240
• 33 McNally E, Sohn R, Frankel S, Leinwand L. Expression of myosin and actin in Escherichia coli . Methods Enzymol 1991; 196: 368-389
• 34 Budzynski AZ, Marder VJ, Menache D, Guillin M. Defect in the gamma polypeptide chain of congenital abnormal fibrinogen (Paris I). Nature 1974; 252: 66-68
• 35 Budzynski AZ, Marder VJ. Plasmic degradation of fibrinogen Paris I. J Lab Clin Med 1976; 88: 817-825
• 36 Mosesson MW, Amrani DL, Menache D. Studies on the structural Abnormality of fibrinogen Paris I. J Clin Invest 1976; 57: 782-790
• 37 Denninger M, Jandrot-Perrus M, Elion J, Bertrand O, Homandberg GA, Mosesson MW, Guillin M. ADP-induced platelet aggregation depends on the conformation or availability of the terminal gamma chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris I. Blood 1987; 70: 558-563
• 38 Hawiger J, Timmons S, Strong DD, Cottrell BA, Riley M, Doolittle RF. Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry 1982; 21: 1407-1413
• 39 Strong DD, Laudano AP, Hawiger J, Doolittle RF. Isolation, characterization and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. Biochemistry 1982; 21: 1414-1420
• 40 Bolyard MG, Lord ST. Expression of altered γ chain molecules in Escherichia coli to study calcium binding and staphylococcal clumping. In: Fibrinogen 4. Current Basic and Clinical Aspects. Matsuda M, Iwanaga S, Takada A, Henschen A. (eds) Elsevier Science Publishers, Amsterdam: 1990. pp 21-24